CYBERDYNE Online Store

🔍

INVESTOR RELATION BACK NUMBER

SEARCH
2022.05.25
【News】Announcement on the Shareholder Benefit Program for FY2022
2022.05.13
【News】Notice of differences between financial forecasts and finalized figures
2022.05.13
Announcement of Financial Results for the Fiscal Year Ending March 31, 2022 (IFRS)
2022.02.14
Announcement of Financial Results for the Nine Months ended December 31, 2021 (IFRS)
2021.12.21
【IR News】Establishment of a subsidiary in Malaysia
2021.11.25
【IR News】Selection of “Growth Market” as the new market division of Tokyo Stock Exchange
2021.11.12
Announcement of Financial Results for the Six Months ended September 30, 2021 (IFRS)
2021.11.08
【IR News】Notice regarding the acquisition of RISE, a U.S. Rehabilitation Medical Institution
2021.10.05
【IR News】Announce on the adoption by AMED Medical Engineering Innovation Promotion Project ~ enables real-time photoacoustic imaging of peripheral capillaries and oxygenation level distribution~
2021.09.06
【IR News】Announcement on large orders for HAL Lumbar Type
~ Signed a long-term contract with Hampshire County Council in the UK ~
2021.08.31
【IR News】Notice regarding the acquisition of C2, developer of smartphone app “JUKUSUI”
2021.08.13
Announcement of Financial Results for the Three Months ended June 30, 2021 (IFRS)
2021.06.01
Announcement on the expansion of Shareholder Benefit Program and establishment of Shareholder Reference Scheme
2021.05.14
Announcement of Financial Results for the Fiscal Year Ending March 31, 2021 (IFRS)
2021.05.14
【News】Notice of differences between financial forecasts and finalized figures
2021.02.17
The Financial Service Agency (FSA) awarded CYBERDYNE’s annual securities report as an excellent example of the disclosure.
2021.02.12
Announcement of Financial Results for the Nine Months ended December 31, 2020 (IFRS)
2021.02.05
CYBERDYNE’s first television ad will go on air
2021.01.26
Announcement on the change of venue for the Extraordinary Meeting of Shareholders
2020.12.14
Announcement on setting of the record date to convene an Extraordinary Meeting of Shareholders and reduction of capital and disposition of surplus
BACK TO TOP